Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07107230) titled 'A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors' on Aug. 5.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Janssen Research & Development, LLC
Condition:
Colorectal Neoplasms
Intervention:
Drug: JNJ-95437446
Recruitment Status: Recruiting
Phase: Phase 1
Date of First Enrollment: July 15, 2025
Target Sample Size: 380
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07107230
Published by HT Digital Conte...